Skip to main content
    N

    NeoGenomics Inc (NEO)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $15.25
    -0.16 (-1.04%)

    Market Cap: $1.99B

    Last updated: Nov 17, 2026 at 4:26 PM ET

    NeoGenomics Inc (NEO) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    NeoGenomics (NEO) has a latest price of $15.25 on Nov 17, 2026, 24.3% below its 52-week high of $20.15. Its price rose 47.5% over the past 12 months. The month-end price rose 115.6% over the 10 years through Oct 2026, a compound annual rate of 8.0%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $53.84 in Dec 2020 and its lowest $4.84 in Jul 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart NEO with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NEO.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 8.4%, and over 6 months it rose 81.8%. The month-end price rose 24.0% over the 3 years through Oct 2026, a compound annual rate of 7.4%.

    PeriodChange
    1 month-7.1%
    3 months-8.4%
    6 months+81.8%
    12 months+47.5%
    12 months, with dividends+47.5%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+24.0%+7.4%
    5 years-62.2%-17.7%
    10 years+115.6%+8.0%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2019, when the price rose 132.0%, and its weakest was 2022, when it fell 72.9%.

    YearCloseChange
    2026 through Oct 2026$17.38+47.8%
    2025$11.76-28.6%
    2024$16.48+1.9%
    2023$16.18+75.1%
    2022$9.24-72.9%
    2021$34.12-36.6%
    2020$53.84+84.1%
    2019$29.25+132.0%
    2018$12.61+42.3%
    2017$8.86+3.4%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 12.7% below its 50-day average of $17.46 and 17.1% above its 200-day average of $13.02.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$15.25
    52-week high$20.15-24.3%
    52-week low$7.07+115.7%
    50-day average$17.46-12.7%
    200-day average$13.02+17.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 76.7%.

    MeasureValue
    1-year beta1.15
    Largest fall, 1 year-45.6%
    Largest fall, 3 years-76.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About NEO

    What is NEO's 1-year price change?

    NeoGenomics's price rose 47.5% over the past 12 months. With dividends included, the 12-month total return was 47.5%.

    What is NEO's 5-year price change?

    NeoGenomics's month-end price fell 62.2% over the 5 years through Oct 2026, a compound annual decline of 17.7%. These figures leave out dividends.

    What is NEO's 52-week high and low?

    NeoGenomics's 52-week high is $20.15 and its 52-week low is $7.07. Its latest price of $15.25 on Nov 17, 2026 is 24.3% below the high.

    What is NEO's beta?

    NeoGenomics's 1-year beta against the S&P 500 is 1.15, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 45.6%.

    Is the NEO chart free?

    Yes. Advanced Charting for NEO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.